Label reference · Immune & inflammatory
Orencia (Abatacept) Injection, Powder, Lyophilized, For Solution Orencia (Abatacept) Injection, Solution — label reference
DailyMed · Retrieved 2026-10-13
Orencia is listed in DailyMed as injection, powder, lyophilized, for solution; injection, solution. Active ingredients: abatacept; abatacept. This reference records product facts and version 35; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- ORENCIA
- Generic product name
- abatacept
- Active ingredient
- abatacept; ABATACEPT
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- SPL author / labeler
- E.R. Squibb & Sons, L.L.C.
- SPL version
- 35
- Published on DailyMed
- 2025-11-18
- SPL effective date
- 2025-11-13
- SPL set ID
- 0836c6ac-ee37-5640-2fed-a3185a0b16eb
Product identity
Product name: ORENCIA
Generic name: abatacept
Active ingredients: abatacept; ABATACEPT
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; INJECTION, SOLUTION
Route: INTRAVENOUS; SUBCUTANEOUS
Label version
DailyMed published this record on 2025-11-18. SPL version: 35. Set ID: 0836c6ac-ee37-5640-2fed-a3185a0b16eb. The SPL effective date is 2025-11-13.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2025-11-18. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.